FI972457A0 - FAS/APO1-reseptorien toiminnan modulaattorit - Google Patents

FAS/APO1-reseptorien toiminnan modulaattorit

Info

Publication number
FI972457A0
FI972457A0 FI972457A FI972457A FI972457A0 FI 972457 A0 FI972457 A0 FI 972457A0 FI 972457 A FI972457 A FI 972457A FI 972457 A FI972457 A FI 972457A FI 972457 A0 FI972457 A0 FI 972457A0
Authority
FI
Finland
Prior art keywords
fas
function
modulators
apo1
receptors
Prior art date
Application number
FI972457A
Other languages
English (en)
Swedish (sv)
Other versions
FI121273B (fi
FI972457A (fi
Inventor
David Wallach
Mark Boldin
Eugene Varfolomeev
Igor Mett
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11200294A external-priority patent/IL112002A0/xx
Priority claimed from IL112692A external-priority patent/IL112692A/en
Priority claimed from IL11461595A external-priority patent/IL114615A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of FI972457A0 publication Critical patent/FI972457A0/fi
Publication of FI972457A publication Critical patent/FI972457A/fi
Application granted granted Critical
Publication of FI121273B publication Critical patent/FI121273B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transmitters (AREA)
  • Peptides Or Proteins (AREA)
  • Secondary Cells (AREA)
  • Gas-Filled Discharge Tubes (AREA)
FI972457A 1994-12-15 1997-06-10 FAS/APO1-reseptorien toiminnan modulaattorit FI121273B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
IL11200294 1994-12-15
IL11200294A IL112002A0 (en) 1994-05-11 1994-12-15 Modulatiors of tnf/ngf superfamily receptors, their preparation and use
IL112692A IL112692A (en) 1995-02-19 1995-02-19 ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R
IL11269295 1995-02-19
IL11461595A IL114615A0 (en) 1995-07-16 1995-07-16 Modulators of the function of fas receptors and other proteins
IL11461595 1995-07-16
US9516542 1995-12-14
PCT/US1995/016542 WO1996018641A1 (en) 1994-12-15 1995-12-14 Modulators of the function of fas/apo1 receptors

Publications (3)

Publication Number Publication Date
FI972457A0 true FI972457A0 (fi) 1997-06-10
FI972457A FI972457A (fi) 1997-06-10
FI121273B FI121273B (fi) 2010-09-15

Family

ID=27271687

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972457A FI121273B (fi) 1994-12-15 1997-06-10 FAS/APO1-reseptorien toiminnan modulaattorit

Country Status (18)

Country Link
EP (1) EP0871645B1 (fi)
JP (1) JP3787355B2 (fi)
KR (1) KR100536394B1 (fi)
CN (1) CN1105725C (fi)
AT (1) ATE377073T1 (fi)
AU (1) AU706401B2 (fi)
CA (1) CA2207815C (fi)
CY (1) CY2586B2 (fi)
DE (1) DE69535634T2 (fi)
DK (1) DK0871645T3 (fi)
ES (1) ES2292172T3 (fi)
FI (1) FI121273B (fi)
HK (1) HK1007248A1 (fi)
MX (1) MX9704501A (fi)
NO (1) NO324725B1 (fi)
PT (1) PT871645E (fi)
UA (1) UA58489C2 (fi)
WO (1) WO1996018641A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) * 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
AU755662B2 (en) * 1995-02-22 2002-12-19 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
ES2242195T3 (es) * 1995-02-22 2005-11-01 YEDA RESEARCH & DEVELOPMENT COMPANY, LTD. Moduladores de proteinas reguladoras.
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US6399327B1 (en) 1995-07-16 2002-06-04 Yeda Research And Development Co. Ltd. Modulators of the function of FAS receptors and other proteins
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
EP0842665A3 (en) * 1996-11-14 2002-12-18 Smithkline Beecham Corporation Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
US5969102A (en) * 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
WO1998049297A1 (en) * 1997-04-25 1998-11-05 American Home Products Corporation Neuronal mort1 isoforms
AU7988698A (en) * 1997-06-26 1999-01-19 Chiron Corporation Human fadd-interacting protein (fip)
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
US6015712A (en) * 1999-07-19 2000-01-18 Isis Pharmaceuticals Inc. Antisense modulation of FADD expression
BRPI0209933B8 (pt) 2001-05-24 2021-05-25 Zymogenetics Inc proteína de fusão, e, molécula de ácido nucleico
US6743630B2 (en) 2002-03-06 2004-06-01 The Trustees Of Columbia University In The City Of New York Method of preparing a protein array based on biochemical protein-protein interaction
AU2006278229B2 (en) 2005-08-09 2011-10-27 Ares Trading S.A. Methods for treating B-cell malignancies using TACI-Ig fusion molecule
JP5118037B2 (ja) 2005-08-09 2013-01-16 ザイモジェネティクス， インコーポレイテッド Ｔａｃｉ融合分子を用いた異常細胞増殖の処置及び予防のための方法
AU2007249223B2 (en) 2006-05-15 2012-08-02 Ares Trading S.A. Methods for treating autoimmune diseases using a TACI-Ig fusion molecule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO178777C (no) * 1994-05-09 1996-05-29 Kvaerner Eng Varmeveksler
US7807783B1 (en) * 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein

Also Published As

Publication number Publication date
ATE377073T1 (de) 2007-11-15
EP0871645B1 (en) 2007-10-31
AU706401B2 (en) 1999-06-17
CN1105725C (zh) 2003-04-16
JPH10510712A (ja) 1998-10-20
AU4602296A (en) 1996-07-03
ES2292172T3 (es) 2008-03-01
CA2207815C (en) 2011-03-29
MX9704501A (es) 1997-10-31
DE69535634D1 (de) 2007-12-13
EP0871645A1 (en) 1998-10-21
CY2586B2 (en) 2009-11-04
NO324725B1 (no) 2007-12-03
NO972716D0 (no) 1997-06-12
CN1169729A (zh) 1998-01-07
PT871645E (pt) 2007-11-14
HK1007248A1 (en) 1999-04-09
CA2207815A1 (en) 1996-06-20
DK0871645T3 (da) 2007-12-03
DE69535634T2 (de) 2008-08-28
WO1996018641A1 (en) 1996-06-20
JP3787355B2 (ja) 2006-06-21
FI121273B (fi) 2010-09-15
KR100536394B1 (ko) 2006-04-21
UA58489C2 (uk) 2003-08-15
EP0871645A4 (en) 1999-11-24
NO972716L (no) 1997-07-11
FI972457A (fi) 1997-06-10

Similar Documents

Publication Publication Date Title
CY2586B2 (en) Modulators of the function of FAS/APO1 receptors
AU2894289A (en) Domain-modified constant region antibodies
DE69632827D1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
AU6402694A (en) Methods and materials relating to the functional domains of dna binding proteins
AR014891A1 (es) Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
EP1798286A3 (en) Mammalian cell membrane proteins and related reagents
AU4423799A (en) Methods and agents for modulating the immune response and inflammation involvingmonocyte and dendritic cell membrane proteins
AU1908395A (en) Antibodies to mammalian natural killer antigens and uses
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
IL133129A0 (en) Prenylcysteine carboxyl methyltransferase dna encoding same and a method of screening for inhibistors thereof
ES8802538A1 (es) Un metodo de producir una proteina capaz de modular la actividad fisiologica de celulas que tienen un receptor de diazepam
DE69430846D1 (de) Für natürliche killerzellen spezifische antigene und sie identifizierende antikörper
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
BG104769A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
AU1695595A (en) Mammalian thymokine genes
AU3063699A (en) Isolated mammalian membrane protein genes and related reagents
DK0868511T3 (da) Genekspression af utrophin
AU532385B2 (en) Natural protein polymer hydrogels
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
DK0870015T3 (da) Xylanaser, gener, der koder for disse, samt anvendelser deraf
WO1999047709A3 (en) Methods for identifying anti-cancer agents
WO2000034335A3 (en) 'death domain' containing receptors
AU5932296A (en) Dna encoding cellular homologue of the sv40 large t antigen
AU6986894A (en) Enhanced expression of protein by using culture medium containing membrane lipids
AU547015B2 (en) Methane fermenter

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 121273

Country of ref document: FI

MA Patent expired